19.09.2013 • NewsGEGeneral Electricoil and gas

General Electric Names New Head of Oil and Gas Unit

General Electric has named Lorenzo Simonelli as chief executive of its oil and gas unit, replacing Dan Heintzelman, who was appointed a vice chairman of the company.

GE has spent over $14 billion since 2007 on acquisitions to build up its oil and gas business, which is the company's fastest growing, with $15 billion in revenues.

"Simonelli has done a good job of trying to bring an underperforming unit into a profitable and growing business for GE," Morningstar analyst Daniel Holland said. "Moving him to energy puts him more in investors' eyes." In his new role, Heintzelman, 56, will focus on services and operations.

Russell Stokes will replace Simonelli, 40, as CEO of GE Transportation.

"Lorenzo transformed GE Transportation from a North American rail business to a global transportation equipment and solutions provider," said Jeff Immelt, GE's CEO. The company is focusing on its core industrial sectors such as energy

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.